Overview

Fluvoxamine maleate

CAS

61718-82-9

Status

Commercial

Fluvoxamine maleate belongs to the group of selective serotonin reuptake inhibitors. The active ingredient increases the concentration of serotonin in the synaptic cleft. It is used for the treatment of obsessive-compulsive disorder.

Description

Formula

C15H21F3N2O2 • C4H4O4

Molecular weight

434.41 g/mol

Molecular size

small

Controlled Substance

no

Precursor

no

Indications

Psychoanaleptics

Your Contact

Marius Hang

Marius Hang

International Division
Director API Export

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany
  • Disclaimer

    The information contained herein is the proprietary information of Midas Pharma GmbH and its affiliates. This information is provided to you solely for your evaluation, to determine your interest in a potential business relationship with Midas Pharma GmbH and/or its affiliates. Midas Pharma GmbH excludes any express or implied representations, guarantees or warranties of whatsoever nature, including but not limited to the warranties for the completeness or accuracy of the information provided herein.

    No information provided herein – including any reference to any product or service – constitutes an offer for sale, or shall be construed as representing an offer for sale. In particular, nothing herein should be construed as a promotion or advertisement for any product, or for the use of any product, that infringes valid patents and/or is not authorized by the laws and regulations of your country of residence.

Complementary Services

Share this page